MIR6892

Across TCGA pan-cancer cohorts, MIR6892 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR6892 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR6892 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6892 expression acts as an unfavorable survival marker.

ESCA, PCPG, and LGG are the cancer types where MIR6892 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
PCPG	OS	Tertile	All	0.524	0.975	<.001	36	view →
LGG	OS	Tertile	All	0.193	0.802	<.001	21	view →
GBM	OS	Tertile	All	0.076	0.415	<.001	18	view →
THCA	DFS	Tertile	II,III,IV	0.159	0.877	<.001	18	view →
THYM	OS	Tertile	All	0.381	0.879	.003	12	view →
COAD	OS	Tertile	All	0.706	0.879	.044	6	view →
HNSC	OS	Tertile	III,IV	0.375	0.661	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR6892–ESCA (OS)

Open the ESCA breakdown →